Singapore, Sept. 18 -- Seoul's bio startup hub 'Seoul Bio Hub' and global pharmaceutical leader 'Celltrion' have joined forces to launch the '2025 Seoul Bio Hub-Celltrion Global Open Innovation (GOI)' programme.

This programme goes beyond a simple competition, serving as a platform designed to help US startups successfully establish themselves in the Asian market.

This GOI targets US-based bio and medical startups, with companies established within the past 7 years eligible to apply. The recruitment areas encompass all technologies suitable for collaboration with Celltrion, including antibodies, peptides, small molecules, formulations, and cell and gene therapies.

The application deadline is September 30, 2025. The selection process wi...